Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins
about
S100A8 and S100A9 in cardiovascular biology and diseasePlasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.Functions of S100 proteins.Macrophage secretome from women with HIV-associated neurocognitive disorders.Serum from Varicose Patients Induces Senescence-Related Dysfunction of Vascular Endothelium Generating Local and Systemic Proinflammatory Conditions.Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsAortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β SignalingHinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer
P2860
Q27024450-35869F45-AD4B-4398-91B3-4031DAD03B50Q30541611-D93D874F-A317-4B56-AC4C-2FA64231413DQ34053623-FE322686-AF4D-4260-BCD9-4EF589000493Q34385625-5EB3B778-0DCB-49BE-A264-D863BB613297Q35152774-AC55E60E-58B9-4D6C-99BD-EE563922C58FQ35757527-1D1D09BE-FD65-482E-931E-8571A1A48606Q37001259-F993664C-A974-449C-A823-901EB030F5D6Q37194373-369C5B73-B92A-45D8-90F6-49CBA68ABD5FQ37479199-81AE7F5D-5B9A-47CC-B228-FADE4B240F02Q37577266-19BBA028-F08F-40E2-A11D-99F34C5E0AE1Q38939435-D32E6920-A1B2-4203-9CDB-48FCDF271743Q39001215-B64FA53A-6BFC-4605-A164-DEC296C342E1Q52914491-1C5175E1-3488-4DCF-B6AA-A4D27F4DB16FQ58579097-6B49AF05-F990-45E6-AEE1-5FF4D6B91D30
P2860
Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@ast
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@en
type
label
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@ast
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@en
prefLabel
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@ast
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@en
P2093
P2860
P356
P1476
Mechanisms of urokinase plasmi ...... eceptor and S100A8/A9 proteins
@en
P2093
David A Dichek
Elizabeth Gold
Helén L Dichek
Jie Hong Hu
Michal Kremen
Ranjini Krishnan
Stephen A Ramsey
Stephen D Farris
P2860
P304
22665-22677
P356
10.1074/JBC.M110.202135
P407
P50
P577
2011-05-02T00:00:00Z